Search for: "Sickle" Results 1 - 20 of 473
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 May 2024, 6:52 am
Browsing through orca memes, there’s an orca as the sickle in the hammer and sickle, with the headline “eat the rich”, and a Soviet-style graphic of a heroic orca emerging under a superyacht. [read post]
11 May 2024, 6:03 pm by Yosi Yahoudai
Taylor says low donations are especially concerning for the approximately 100,000 Americans who suffer from sickle cell disease. [read post]
10 May 2024, 1:36 pm by Greg Reed
   Sickle cell anemia is an inherited form of anemia affecting the shape of red blood cells, blocking blood flow and causing pain and organ damage. [read post]
The Casgevy treatment uses the CRISPR/Cas-9 technology to edit patients’ blood stem cells to increase the production of fetal hemoglobin, which is not affected by the sickle cell mutation, thereby diluting the affected sickled blood cells. [read post]
1 Mar 2024, 10:40 am by Daily Record Staff
’s ACMG to give specially adapted bikes to kids with autism, sickle cell disease appeared first on Maryland Daily Record. [read post]
29 Feb 2024, 1:11 pm by Lexi Coghe
Duane Bonds served as Deputy Chief of the Sickle Cell Disease Branch of the Division of Blood Diseases and Resources within the National Institutes of Health in 1999. [read post]
26 Feb 2024, 5:00 am by Adithi Iyer
Much has been made of recently discussed CAR-T cell therapies for cancer, which have been around since 2017, and in-human sickle cell treatment Casgevy. [read post]
8 Feb 2024, 6:15 am by JD Hull
The best book on Sickle's amazing, checkered and long public life is Thomas Keneally's American Scoundrel: The Life of the Notorious Civil War General Dan Sickles. [read post]
28 Jan 2024, 9:07 pm by Patent Docs
     Related StoriesFDA Approves Another Interchangeable BiosimilarFDA Approves Sandoz Biosimilar for Tysabri®FDA Signals Willingness to Approve CRISPR-Based Treatment for Sickle Cell Anemia  [read post]
17 Jan 2024, 7:02 am by FRANK VINLUAN - MEDCITY NEWS
Last month, the one-time treatment won its first FDA nod for treating sickle cell disease. [read post]
27 Dec 2023, 9:48 pm by Patent Docs
     Related StoriesFDA Approves Sandoz Biosimilar for Tysabri®FDA Signals Willingness to Approve CRISPR-Based Treatment for Sickle Cell AnemiaFDA Approves Biogen Biosimilar for Genentech's Actemra®  [read post]
14 Dec 2023, 9:05 pm by William McDonald
Lewis Hsu, Chief Medical Officer of the Sickle Cell Disease Association of America, noted that the approval “is something that we’ve been waiting for in the sickle cell community for basically 70 years. [read post]
13 Dec 2023, 10:16 am by Stephen Honig
It may be naive to think that anti-trust enforcement will solve all the cost burden of modern medicine (just the other day the exciting news of development of a drug to defeat Sickle Cell was tempered by its $2.2 Million price tag); government is going to have to do things that border on socialized medicine, or price control in the context of a national health crisis, as the reality of rapidly expanding medical expertise will incur huge costs which must be either recovered by market pricing… [read post]
11 Dec 2023, 12:04 pm by Alyzza Austriaco
The new medication, called Casgevy, made by Vertex Pharmaceuticals and CRISPR Therapeutics, is used to treat patients with sickle cell disease. ( STAT ) —Compiled by SNCJ Managing Editor KOREY CLARK Please visit our webpage to connect with a State Net representative and learn how the State Net legislative and regulatory tracking solution can help you identify, track, analyze and report on relevant legislative and regulatory developments. [read post]
8 Dec 2023, 9:22 am by Associated Press
Regulators approved two new gene therapies for sickle cell disease that doctors hope can cure the painful, inherited blood disorder. [read post]
25 Nov 2023, 6:00 am by M@jux-@dmin
  Similarly, the listing under Section 7.05 for sickle cell disease requires at least three hospitalizations in a year, lasting at least two days each time. [read post]
20 Nov 2023, 9:48 am by FRANK VINLUAN - MEDCITY NEWS
Casgevy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is now approved in the United Kingdom for treating the blood disorders sickle cell disease and beta thalassemia. [read post]